Balyasny Asset Management
HCM icon

Balyasny Asset Management’s HUTCHMED HCM Stock Holding History

Balyasny Asset Management’s Portfolio HCM Stock Details HCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-19,076
Closed -$169K – 2955
2022
Q3 		$169K Buy
+19,076
New +$240K ﹤0.01% 2335

Other funds holding HCM

MGIM
M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CGIM
Cannon Global Investment Management Davie, Florida $51.2M AUM 49.67% 1-Year Est. Return
AG
AIA Group Hong Kong $6.88B AUM 20.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Balyasny Asset Management's HCM Position: Q4 2022 in Review

Balyasny Asset Management sold out of HUTCHMED (HCM) in Q4 2022, closing a stake of 19,076 shares — an estimated $169K sold.

Balyasny Asset Management first reported a position in HCM in Q3 2022 and held it in 1 quarter. The position peaked at $169K in Q3 2022. 84 funds tracked by Wall St. Rank hold HCM as of Q4 2022.

  • Balyasny Asset Management reported no remaining HUTCHMED position as of Q4 2022 after selling out during the quarter.
  • Balyasny Asset Management sold 19,076 HUTCHMED shares in Q4 2022, an estimated $169K.
  • Balyasny Asset Management first reported a position in HUTCHMED in Q3 2022 and held it in 1 quarter.
  • Balyasny Asset Management's HUTCHMED position peaked at $169K in Q3 2022.
  • 84 funds tracked by Wall St. Rank held HUTCHMED as of Q4 2022.

Based on Balyasny Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.